PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
 
Proc R Soc Med. 1966 April; 59(4): 287–292.
PMCID: PMC1900614

Uric acid production with particular reference to the role of xanthine oxidase and its inhibition.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (911K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • AYVAZIAN JH. XANTHINURIA AND HEMOCHROMATOSIS. N Engl J Med. 1964 Jan 2;270:18–22. [PubMed]
  • BAILIE MJ, MORTON RK. Comparative properties of microsomes from cow's milk and from mammary gland. 1. Enzymic activities. Biochem J. 1958 May;69(1):35–44. [PubMed]
  • BERGMANN F, DIKSTEIN S. Studies on uric acid and related compounds. III. Observations on the specificity of mammalian xanthine oxidases. J Biol Chem. 1956 Dec;223(2):765–780. [PubMed]
  • BLAIR JA. Isolation of isoxanthopterin from human urine. Biochem J. 1958 Mar;68(3):385–387. [PubMed]
  • Booth VH. The specificity of xanthine oxidase. Biochem J. 1938 Mar;32(3):494–502. [PubMed]
  • DENT CE, PHILPOT GR. Xanthinuria, an inborn error (or deviation) of metabolism. Lancet. 1954 Jan 23;266(6804):182–185. [PubMed]
  • DICKINSON CJ, SMELLIE JM. Xanthinuria. Br Med J. 1959 Dec 5;2(5161):1217–1221. [PMC free article] [PubMed]
  • Dixon M. Studies on Xanthine Oxidase: The Specificity of the System. Biochem J. 1926;20(4):703–718. [PubMed]
  • ENGELMAN K, WATTS RW, KLINENBERG JR, SJOERDSMA A, SEEGMILLER JE. CLINICAL, PHYSIOLOGICAL AND BIOCHEMICAL STUDIES OF A PATIENT WITH XANTHINURIA AND PHEOCHROMOCYTOMA. Am J Med. 1964 Dec;37:839–861. [PubMed]
  • GOLDFINGER S, KLINENBERG JR, SEEGMILLER JE. THE RENAL EXCRETION OF OXYPURINES. J Clin Invest. 1965 Apr;44:623–628. [PMC free article] [PubMed]
  • GOLDTHWAIT DA, GREENBERG GR, PEABODY RA. The involvement of 5-phosphoribosylamine in the biosynthesis of glycinamide ribotide. Biochim Biophys Acta. 1955 Sep;18(1):148–149. [PubMed]
  • GOTS JS. Purine metabolism in bacteria. V. Feed-back inhibition. J Biol Chem. 1957 Sep;228(1):57–66. [PubMed]
  • GOTS JS, GOLDSTEIN J. Specific action of adenine as a feedback inhibitor of purine biosynthesis. Science. 1959 Sep 11;130(3376):622–623. [PubMed]
  • HALL AP, HOLLOWAY VP, SCOTT JT. 4-HYDROXYPYRAZOLO (3,4-D) PYRIMIDINE (HPP) IN THE TREATMENT OF GOUT: PRELIMINARY OBSERVATIONS. Ann Rheum Dis. 1964 Nov;23:439–446. [PMC free article] [PubMed]
  • HENDERSON JF. Feedback inhibition of purine biosynthesis in ascites tumor cells. J Biol Chem. 1962 Aug;237:2631–2635. [PubMed]
  • JONES OW, Jr, ASHTON DM, WYNGAARDEN JB. Accelerated turnover of phosphoribosylpyrophosphate, a purine nucleotide precursor, in certain gouty subjects. J Clin Invest. 1962 Sep;41:1805–1815. [PMC free article] [PubMed]
  • KLENOW H. The enzymic oxidation and assay of adenine. Biochem J. 1952 Jan;50(3):404–407. [PubMed]
  • KLINENBERG JR, GOLDFINGER SE, SEEGMILLER JE. THE EFFECTIVENESS OF THE XANTHINE OXIDASE INHIBITOR ALLOPURINOL IN THE TREATMENT OF GOUT. Ann Intern Med. 1965 Apr;62:639–647. [PubMed]
  • MCCOLLISTER RJ, GILBERT WR, Jr, ASHTON DM, WYNGAARDEN JB. PSEUDOFEEDBACK INHIBITION OF PURINE SYNTHESIS BY 6-MERCAPTOPURINE RIBONUCLEOTIDE AND OTHER PURINE ANALOGUES. J Biol Chem. 1964 May;239:1560–1563. [PubMed]
  • MAGER J, MAGASANIK B. Guanosine 5'-phosphate reductase and its role in the interconversion of purine nucleotides. J Biol Chem. 1960 May;235:1474–1478. [PubMed]
  • POMALES R, BIEBER S, FRIEDMAN R, HITCHINGS GH. Augmentation of the incorporation of hypoxanthine into nucleic acids by the administration of an inhibitor of xanthine oxidase. Biochim Biophys Acta. 1963 May 28;72:119–120. [PubMed]
  • PRAETORIUS E, KIRK JE. Hypouricemia: with evidence for tubular elimination of uric acid. J Lab Clin Med. 1950 Jun;35(6):865–868. [PubMed]
  • HURST V, GROSSMAN M, SUTTER VL, FENNELL J. XANTHINE OXIDASE AND IRON. N Engl J Med. 1964 Mar 5;270:534–536. [PubMed]
  • SEEGMILLER JE, GRAYZEL AI, LASTER L, LIDDLE L. Uric acid production in gout. J Clin Invest. 1961 Jul;40:1304–1314. [PMC free article] [PubMed]
  • SEEGMILLER JE, LASTER L, STETTEN D., Jr Incorporation of 4-amino-5-imidazolecarboxamide-4-C13 into uric acid in the normal human. J Biol Chem. 1955 Oct;216(2):653–662. [PubMed]
  • VILLELA GG, MITIDIERI E, AFFONSO OR. Intracellular distribution of xanthine oxidase in the rat liver. Nature. 1955 Jun 18;175(4468):1087–1087. [PubMed]
  • WATTS RW, ENGELMAN K, KLINENBERG JR, SEEGMILLER JE, SJOERDSMA A. ENZYME DEFECT IN A CASE OF XANTHINURIA. Nature. 1964 Jan 25;201:395–396. [PubMed]
  • Watts RW, Watkins PJ, Matthias JQ, Gibbs DA. Allopurinal and acute uric acid nephropathy. Br Med J. 1966 Jan 22;1(5481):205–208. [PMC free article] [PubMed]
  • Watts RW, Watts JE, Seegmiller JE. Xanthine oxidase activity in human tissues and its inhibition by allopurinol (4-hydroxypyrazolo[3,4-d] pyrimidine). J Lab Clin Med. 1965 Oct;66(4):688–697. [PubMed]
  • WYNGAARDEN JB, ASHTON DM. The regulation of activity of phosphoribosyl-pyrophosphate amidotransferase by purine ribonacleotides: a potential feedback control of purine biosyntoesis. J Biol Chem. 1959 Jun;234(6):1492–1496. [PubMed]
  • WYNGAARDEN JB, RUNDLES RW, METZ EN. ALLOPURNOL IN THE TREATMENT OF GOUT. Ann Intern Med. 1965 Apr;62:842–847. [PubMed]
  • WYNGAARDEN JB, SEEGMILLER JE, LASTER L, BLAIR AE. Utilization of hypoxanthine, adenine and 4-amino-5-imidazole-carboxamide for uric acid synthesis in man. Metabolism. 1959 Jul 1;8(4 Pt 1):455–464. [PubMed]
  • YUE TF, GUTMAN AB. EFFECT OF ALLOPURINOL (4-HYDROXYPYRAZOLO-(3,4-D)PYRIMIDINE) ON SERUM AND URINARY URIC ACID IN PRIMARY AND SECONDARY GOUT. Am J Med. 1964 Dec;37:885–898. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press